Core Viewpoint - Heartflow, a cardiac imaging software provider, is set to launch its IPO with a price range of $15 to $17 per share, aiming to raise $200 million and achieve a fully diluted market capitalization of $1.4 billion [1] Company Overview - Heartflow is headquartered in Mountain View, California, and was founded in 2007 [1] - The company specializes in non-invasive solutions for diagnosing and managing coronary artery disease (CAD) [1] - As of March 31, 2025, Heartflow's platform has been used to assess over 400,000 patients for CAD, with 132,000 assessments conducted in 2024 alone [1] Technology and Innovation - Heartflow's platform utilizes artificial intelligence and advanced computational fluid dynamics to create personalized 3D models of patients' hearts [1] - The technology provides actionable insights regarding blood flow, vascular narrowing, plaque volume, and plaque composition [1] Financials and Market Position - For the 12 months ending March 31, 2025, Heartflow reported revenues of $136 million [1] - The company plans to list on NASDAQ under the ticker symbol "HTFL" [1] Underwriters and IPO Timeline - The joint underwriters for the IPO include JPMorgan, Morgan Stanley, and Piper Sandler [1] - The expected pricing date for the IPO is during the week of August 4 [1]
心脏成像软件供应商Heartflow(HTFL.US)IPO定价15-17美元/股 拟筹资2亿美元
智通财经网·2025-08-04 07:17